|
JPS59152348A
(ja)
*
|
1983-02-19 |
1984-08-31 |
Kaken Pharmaceut Co Ltd |
ビフエニリルプロピオン酸エステル誘導体およびその製造法
|
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
|
JPH0768117B2
(ja)
*
|
1983-05-06 |
1995-07-26 |
ベスター・インコーポレイテツド |
薬剤放出調整用小胞製剤
|
|
CA1237670A
(en)
*
|
1983-05-26 |
1988-06-07 |
Andrew S. Janoff |
Drug preparations of reduced toxicity
|
|
US5059591B1
(en)
*
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
|
JPS601122A
(ja)
*
|
1983-06-20 |
1985-01-07 |
Green Cross Corp:The |
ビフエニリルプロピオン酸誘導体脂肪乳剤
|
|
CA1264162A
(en)
*
|
1984-03-15 |
1990-01-02 |
Manfred Breuninger |
Glycerol ether phosphatides
|
|
JPS60208910A
(ja)
*
|
1984-03-31 |
1985-10-21 |
Green Cross Corp:The |
水難溶性薬物・リン脂質複合体の製造方法
|
|
US4891208A
(en)
*
|
1985-04-10 |
1990-01-02 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
US5231112A
(en)
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
|
PT78628B
(en)
*
|
1984-05-02 |
1986-06-18 |
Liposome Co Inc |
Pharmaceutical composition with reduced toxicity
|
|
CA1264668A
(en)
*
|
1984-06-20 |
1990-01-23 |
Pieter R. Cullis |
Extrusion techniques for producing liposomes
|
|
US5077056A
(en)
*
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
CA1270198C
(en)
*
|
1984-08-08 |
1990-06-12 |
Marcel B Bally |
ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
JPS61100518A
(ja)
*
|
1984-10-22 |
1986-05-19 |
Ono Pharmaceut Co Ltd |
ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
|
|
AU587600B2
(en)
*
|
1985-01-11 |
1989-08-24 |
Regents Of The University Of California, The |
Method for preserving liposomes
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4753788A
(en)
*
|
1985-01-31 |
1988-06-28 |
Vestar Research Inc. |
Method for preparing small vesicles using microemulsification
|
|
CA1256372A
(en)
*
|
1985-04-11 |
1989-06-27 |
Koichiro Miyazima |
Process for producing liposome composition
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
IL79114A
(en)
*
|
1985-08-07 |
1990-09-17 |
Allergan Pharma |
Method and composition for making liposomes
|
|
US5622713A
(en)
*
|
1985-09-17 |
1997-04-22 |
The Regents Of The University Of California |
Method of detoxifying animal suffering from overdose
|
|
US4766046A
(en)
*
|
1985-09-27 |
1988-08-23 |
Liposome Technology, Inc. |
Stabilized liposome/amphotericin composition and method
|
|
IE58981B1
(en)
*
|
1985-10-15 |
1993-12-15 |
Vestar Inc |
Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
|
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
|
US4861580A
(en)
*
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
|
SE8505047L
(sv)
*
|
1985-10-25 |
1987-04-26 |
Nutritional Int Res Inst |
Fettemulsion
|
|
US4806343A
(en)
*
|
1986-03-13 |
1989-02-21 |
University Of Southwestern Louisiana |
Cryogenic protectant for proteins
|
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
US4946683A
(en)
*
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
|
DE68916439T2
(de)
*
|
1988-10-05 |
1994-10-20 |
Vestar Inc |
Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
|
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
|
US5091187A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
ES2089227T3
(es)
*
|
1990-07-31 |
1996-10-01 |
Liposome Co Inc |
Acumulacion de aminoacidos y peptidos en el interior de liposomas.
|
|
US5462740A
(en)
*
|
1993-09-17 |
1995-10-31 |
Athena Neurosciences, Inc. |
Rectally-administered, epileptic-seizure-inhibiting composition
|
|
US5840328A
(en)
*
|
1994-01-11 |
1998-11-24 |
The Liposome Company, Inc. |
Treatment using arachidonic acid metabolite and particulate formulations
|
|
EP0783295A1
(en)
*
|
1994-09-23 |
1997-07-16 |
The Liposome Company, Inc. |
Method of producing a lyophilized liposome product
|
|
US6117432A
(en)
*
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
|
US6689370B1
(en)
|
1995-04-20 |
2004-02-10 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
|
FR2733151B1
(fr)
*
|
1995-04-20 |
1997-05-23 |
Seppic Sa |
Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
|
|
US20040208922A1
(en)
*
|
1995-06-07 |
2004-10-21 |
The Regents Of The University Of California |
Method for loading lipid like vesicles with drugs or other chemicals
|
|
WO1997014407A1
(en)
*
|
1995-10-17 |
1997-04-24 |
Research Triangle Pharmaceuticals |
Insoluble drug delivery
|
|
GB9609779D0
(en)
|
1996-05-10 |
1996-07-17 |
Univ Bruxelles |
Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US7255877B2
(en)
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
US5827532A
(en)
*
|
1997-01-31 |
1998-10-27 |
The Reagents Of The University Of California |
Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
|
|
IT1289938B1
(it)
*
|
1997-02-20 |
1998-10-19 |
Angelini Ricerche Spa |
Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
|
|
US6004925A
(en)
*
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6046166A
(en)
*
|
1997-09-29 |
2000-04-04 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6518412B1
(en)
*
|
1997-09-29 |
2003-02-11 |
Jean-Louis Dasseux |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6037323A
(en)
|
1997-09-29 |
2000-03-14 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6287590B1
(en)
*
|
1997-10-02 |
2001-09-11 |
Esperion Therapeutics, Inc. |
Peptide/lipid complex formation by co-lyophilization
|
|
IL137734A0
(en)
*
|
1998-02-11 |
2001-10-31 |
Res Triangle Pharm Ltd |
Method and composition for treatment of inflammatory conditions
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU764001B2
(en)
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
|
WO2000010531A1
(en)
|
1998-08-19 |
2000-03-02 |
Rtp Pharma Inc. |
Injectable aqueous dispersions of propofol
|
|
RU2233654C2
(ru)
|
1998-11-20 |
2004-08-10 |
Ртп Фарма Инк. |
Диспергируемые стабилизированные фосфолипидом микрочастицы
|
|
EP1276465B1
(en)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Improved water-insoluble drug particle process
|
|
US6653062B1
(en)
*
|
2000-07-26 |
2003-11-25 |
Wisconsin Alumni Research Foundation |
Preservation and storage medium for biological materials
|
|
AU8847101A
(en)
|
2000-08-31 |
2002-03-13 |
Rtp Pharma Inc |
Milled particles
|
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
WO2002058622A2
(en)
*
|
2000-11-09 |
2002-08-01 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
ATE357216T1
(de)
*
|
2001-02-22 |
2007-04-15 |
Jagotec Ag |
Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
|
|
WO2003030864A1
(en)
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
CA2503087A1
(en)
*
|
2005-03-30 |
2006-09-30 |
Medicure International Inc. |
Intravenous formulations of pyridoxal 5'-phosphate and method of preparation
|
|
US8163699B2
(en)
*
|
2006-06-01 |
2012-04-24 |
Montreal Heart Institute |
Method for the treatment of valvular disease
|
|
PT2939683T
(pt)
|
2009-02-16 |
2017-04-07 |
Cerenis Therapeutics Holding Sa |
Miméticos da apolipoproteína a-i
|